Profiling of Humoral Response to Influenza A(H1N1)pdm09 Infection and Vaccination Measured by a Protein Microarray in Persons with and without History of Seasonal Vaccination

Background The influence of prior seasonal influenza vaccination on the antibody response produced by natural infection or vaccination is not well understood. Methods We compared the profiles of antibody responses of 32 naturally infected subjects and 98 subjects vaccinated with a 2009 influenza A(H1N1) monovalent MF59-adjuvanted vaccine (Focetria®, Novartis), with and without a history of seasonal influenza vaccination. Antibodies were measured by hemagglutination inhibition (HI) assay for influenza A(H1N1)pdm09 and by protein microarray (PA) using the HA1 subunit for seven recent and historic H1, H2 and H3 influenza viruses, and three avian influenza viruses. Serum samples for the infection group were taken at the moment of collection of the diagnostic sample, 10 days and 30 days after onset of influenza symptoms. For the vaccination group, samples were drawn at baseline, 3 weeks after the first vaccination and 5 weeks after the second vaccination. Results We showed that subjects with a history of seasonal vaccination generally exhibited higher baseline titers for the various HA1 antigens than subjects without a seasonal vaccination history. Infection and pandemic influenza vaccination responses in persons with a history of seasonal vaccination were skewed towards historic antigens. Conclusions Seasonal vaccination is of significant influence on the antibody response to subsequent infection and vaccination, and further research is needed to understand the effect of annual vaccination on protective immunity.

[1]  V. Deubel,et al.  Heterosubtypic Antibody Response Elicited with Seasonal Influenza Vaccine Correlates Partial Protection against Highly Pathogenic H5N1 Virus , 2011, PloS one.

[2]  A. Osterhaus,et al.  Haemagglutination-inhibiting antibody to influenza virus. , 2003, Developments in biologicals.

[3]  Eduardo Lazcano-Ponce,et al.  Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City , 2009, BMJ : British Medical Journal.

[4]  S. D. de Vlas,et al.  Serological reports of human infections of H7 and H9 avian influenza viruses in northern China. , 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[5]  Stephen S. H. Huang,et al.  Seasonal H1N1 Influenza Virus Infection Induces Cross-Protective Pandemic H1N1 Virus Immunity through a CD8-Independent, B Cell-Dependent Mechanism , 2011, Journal of Virology.

[6]  M. Koopmans,et al.  Immunogenicity, Boostability, and Sustainability of the Immune Response after Vaccination against Influenza A Virus (H1N1) 2009 in a Healthy Population , 2011, Clinical and Vaccine Immunology.

[7]  M. Ventresca,et al.  Prevalence of Antibodies against Seasonal Influenza A and B Viruses in Children in Netherlands , 2011, Clinical and Vaccine Immunology.

[8]  R. Brunham,et al.  Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age. , 2011, The Journal of infectious diseases.

[9]  D. Jackson,et al.  Antigenic determinants of influenza virus hemagglutinin. III. Competitive binding of antibodies directed against "common" and "strain-specific" antigenic determinants of A/Memphis/72 hemagglutinin. , 1979, Journal of Immunology.

[10]  G. Rimmelzwaan,et al.  Yearly influenza vaccinations: a double-edged sword? , 2009, The Lancet. Infectious diseases.

[11]  Marion Koopmans,et al.  Age-dependent patterns of infection and severity explaining the low impact of 2009 influenza A (H1N1): evidence from serial serologic surveys in the Netherlands. , 2011, American journal of epidemiology.

[12]  H. Kelly,et al.  Interim analysis of pandemic influenza (H1N1) 2009 in Australia: surveillance trends, age of infection and effectiveness of seasonal vaccination. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[13]  T. Kuiken,et al.  Cross-protective immunity against influenza pH1N1 2009 viruses induced by seasonal influenza A (H3N2) virus is mediated by virus-specific T-cells. , 2011, The Journal of general virology.

[14]  Laura C. Rosella,et al.  Association between the 2008–09 Seasonal Influenza Vaccine and Pandemic H1N1 Illness during Spring–Summer 2009: Four Observational Studies from Canada , 2010, PLoS medicine.

[15]  A. Osterhaus,et al.  Annual Vaccination against Influenza Virus Hampers Development of Virus-Specific CD8+ T Cell Immunity in Children , 2011, Journal of Virology.

[16]  M. Koopmans,et al.  Course of pandemic influenza A(H1N1) 2009 virus infection in Dutch patients , 2012, Influenza and other respiratory viruses.

[17]  J. Belmont,et al.  Prior Infections With Seasonal Influenza A/H1N1 Virus Reduced the Illness Severity and Epidemic Intensity of Pandemic H1N1 Influenza in Healthy Adults , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  J. Yewdell,et al.  Heterosubtypic immunity to influenza A virus: where do we stand? , 2008, Microbes and infection.

[19]  M. Koopmans,et al.  Profiling of humoral immune responses to influenza viruses by using protein microarray. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[20]  Martin H. Koldijk,et al.  New Class of Monoclonal Antibodies against Severe Influenza: Prophylactic and Therapeutic Efficacy in Ferrets , 2010, PloS one.

[21]  Christopher L. Perdue,et al.  Seasonal Influenza Vaccine and Protection against Pandemic (H1N1) 2009-Associated Illness among US Military Personnel , 2010, PloS one.

[22]  Libo Dong,et al.  Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. , 2009, The New England journal of medicine.

[23]  Gira Bhabha,et al.  Antibody Recognition of a Highly Conserved Influenza Virus Epitope , 2009, Science.

[24]  C. Agrati,et al.  Cross-subtype Immunity against Avian Influenza in Persons Recently Vaccinated for Influenza , 2008, Emerging infectious diseases.

[25]  D. Jackson,et al.  Antigenic Determinants of Influenza Virus Hemagglutinin , 1979, The Journal of Immunology.

[26]  David Bulnes-Abundis,et al.  Specific Recognition of Influenza A/H1N1/2009 Antibodies in Human Serum: A Simple Virus-Free ELISA Method , 2010, PloS one.

[27]  K. Subbarao,et al.  Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine. , 2010, The Journal of clinical investigation.

[28]  Deborah Middleton,et al.  Multiple infections with seasonal influenza A virus induce cross-protective immunity against A(H1N1) pandemic influenza virus in a ferret model. , 2010, The Journal of infectious diseases.

[29]  M. Weatherall,et al.  Effectiveness of the 2009 seasonal influenza vaccine against pandemic influenza A(H1N1)2009 in healthcare workers in New Zealand, June-August 2009. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[30]  T. Kuiken,et al.  Vaccination against Seasonal Influenza A/H3N2 Virus Reduces the Induction of Heterosubtypic Immunity against Influenza A/H5N1 Virus Infection in Ferrets , 2011, Journal of Virology.